NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 109 filers reported holding NEVRO CORP in Q3 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $15,503,000 | -42.0% | 353,698 | -4.4% | 0.03% | -25.7% |
Q1 2022 | $26,748,000 | -11.4% | 369,808 | -0.6% | 0.04% | -2.8% |
Q4 2021 | $30,174,000 | -30.5% | 372,199 | -0.2% | 0.04% | -32.1% |
Q3 2021 | $43,419,000 | -8.9% | 373,083 | -37.5% | 0.05% | -44.8% |
Q2 2018 | $47,666,000 | -6.4% | 596,939 | +1.6% | 0.10% | -6.8% |
Q1 2018 | $50,943,000 | +74.1% | 587,787 | +38.7% | 0.10% | +87.3% |
Q4 2017 | $29,268,000 | -25.7% | 423,923 | -2.2% | 0.06% | -24.7% |
Q3 2017 | $39,410,000 | +38.3% | 433,649 | +13.2% | 0.07% | +35.2% |
Q2 2017 | $28,500,000 | -23.4% | 382,917 | -3.6% | 0.05% | -26.0% |
Q1 2017 | $37,220,000 | +22.9% | 397,224 | -4.7% | 0.07% | +15.9% |
Q4 2016 | $30,294,000 | -49.7% | 416,928 | -27.7% | 0.06% | -47.5% |
Q3 2016 | $60,181,000 | +39.4% | 576,506 | -1.5% | 0.12% | +30.4% |
Q2 2016 | $43,172,000 | +34.4% | 585,310 | +2.5% | 0.09% | +37.3% |
Q1 2016 | $32,131,000 | +13.5% | 571,120 | +36.2% | 0.07% | +19.6% |
Q4 2015 | $28,313,000 | +143.3% | 419,395 | +67.2% | 0.06% | +133.3% |
Q3 2015 | $11,635,000 | – | 250,799 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
Venator Management LLC | 25,000 | $480,500 | 0.18% |
DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |